Vitamins China E-News

Publication: Monthly on the
Published by CCM

Vitamins China E-News provides you with real-time intelligence on China's vitamins market.
 
China is the world's largest exporter of vitamins, while the domestic market has also expanded rapidly in recent years thanks to growing demand from the feed and pharmaceuticals markets. Now, competition in the industry is shifting from producing API to higher-margin pharmaceutical-grade products, while China’s tougher stance on environmental protection is also having an effect.
 
Vitamins China E-News will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire vitamins industry chain, from raw materials to end consumption. This includes:
      
  • Breaking news from China and abroad
  •   
  • The latest market data, including price information for raw materials, intermediates and end products, import/export data, production, consumption, operating rates, etc.
  •   
  • In-depth analysis of market trends, Chinese government policy, the performance of leading Chinese producers, M&A, new technologies, and more
  •   
  • Expert commentary from industry insiders, including regular guest articles and interviews with insiders at leading Chinese manufacturers, associations and government organizations
Vitamins China E-News is also available as a monthly newsletter, which can be downloaded in PDF format. For more information, you can download a free sample below, or get in touch with us directly by emailing econtact@cnchemicals.com or calling +86-20-37616606.


  • Future-issues subscription

Starting from the issue of
202404
lasting for


0.5 1 1.5 2 2.5 3


year(s)  , is priced at


  • Single user license:
    USD 2,950.00
  • Corporate license:
    USD 7,375.00

All the prices on this website exclude VAT.

<<
  • 202404
  • 202403
  • 202402
  • 202401
  • 202312
  • 202311
  • 202310
  • 202309
  • 202308
  • 202307
  • 202306
  • 202305
  • 202304
  • 202303
  • 202302
  • 202301
  • 202212
  • 202211
  • 202210
  • 202209
  • 202208
  • 202207
  • 202206
  • 202205
  • 202204
  • 202203
  • 202202
  • 202201
  • 202112
  • 202111
  • 202110
  • 202109
  • 202108
  • 202107
  • 202106
  • 202105
  • 202104
  • 202103
  • 202102
  • 202101
  • 202012
  • 202011
  • 202010
  • 202009
  • 202008
  • 202007
  • 202006
  • 202005
  • 202004
  • 202003
  • 202002
  • 202001
  • 201912
  • 201911
  • 201910
  • 201909
  • 201908
  • 201907
  • 201906
  • 201905
  • 201904
  • 201903
  • 201902
  • 201901
  • 201812
  • 201811
  • 201810
  • 201809
  • 201808
  • 201807
  • 201806
  • 201805
  • 201804
  • 201803
  • 201802
  • 201801
  • 201712
  • 201711
  • 201710
  • 201709
  • 201708
  • 201707
  • 201706
  • 201705
  • 201704
  • 201703
  • 201702
  • 201701
  • 201612
  • 201611
  • 201610
  • 201609
  • 201608
  • 201607
  • 201606
  • 201605
  • 201604
  • 201603
  • 201602
  • 201601
  • 201512
  • 201511
  • 201510
  • 201509
  • 201508
  • 201507
  • 201506
  • 201505
  • 201504
  • 201503
  • 201502
  • 201501
  • 201412
  • 201411
  • 201410
>>

Main Content of Vitamins China E-News 202004

Price of this issue :
USD 98

Published on 30th April, 2020

Published on 30th April, 2020

Jan.–Feb. 2020 saw a weak performance in domestic vitamin exports. Compared with the same period in 2019, exports volume and export price both fell from the same period last year, with the former falling by 41,270.117 tonnes, down by 2.16% YoY and the latter decreased by 15.07% to USD329,586,708.

Published on 30th April, 2020

On 25 March, Brother Enterprises declaimed that its second-tier subsidiary Brother CISA planned to suspend production from the following day as requested by South Africa government and it expected a resumption on 17 April. However, the company announced again on 18 April that Brother CISA could not resume production as planned.

Published on 30th April, 2020

Published on 30th April, 2020

On 24 March, the intended approval for the EIA report of Beite Pharmaceutical's 400 t/a folic acid project was published for public opinions.

Published on 30th April, 2020

Published on 30th April, 2020

Two major vitamin C companies published their 2019 performance at the end of March. CSPC PHARMA saw weak performances in its vitamin C and antibiotics, while North Pharmaceutical's 2019 results reached a peak out of the three years since 2017.

Published on 30th April, 2020

The Administration for Market Regulation issued a notice on 14 April to fine three enterprises for their monopoly actions on API, with a penalty of USD45.99 million (RMB3,255 million). It is the heaviest fine for an antitrust case in China's API industry since the Anti-Monopoly Law came into force in 2008.

Published on 29th April, 2020

Published on 29th April, 2020

Published on 29th April, 2020

Published on 29th April, 2020

Published on 29th April, 2020

Published on 29th April, 2020

on 21 March, Adisseo released its annual performance report of 2019. The stable performance of its functional products was attributed to the growing production in methionine and the stable production of methionine of vitamin.

Published on 28th April, 2020

As cholesterol from animal brains were banned and gelatin became in short, domestic large-scale VD3 producers successively raised their quotations in April 2020. The price hike was sharper than a month ago.

Published on 27th April, 2020

Published on 27th April, 2020

On March 28, VTR announced that it will provide a joint and several liability guarantee for Hong Ying Biotech and its subsidiaries to apply for comprehensive credit from banks in 2020, with a guarantee amount of USD19.08 million (RMB135 million).

Published on 25th April, 2020

Four months into 2020, COVID-19 has raged around the world. Since China is the world's largest vitamin producer, the epidemic has brought changes to its domestic market.

Published on 24th April, 2020

Published on 21st April, 2020

Published on 21st April, 2020

Published on 13th April, 2020

Published on 13th April, 2020

Published on 9th April, 2020

CSPC Xinnuowei (stock code: 300765), released its annual performance report of 2019, which was the first annual results after it was listed on the SSE GEM on 22 March, 2019.

CCM Customized Service on Market Research

Do you want Import & Export Analysis, Financial Data, Cost Analysis, Supply Chain Research etc. ? We will customize the specific research for you, in case the services listed above does not meet your precise requirements. Our product and industry research in China’s agriculture, chemicals, food & ingredients and life science markets will comprehensively cover the business information, which is able to help you arrive at strategic and profitable business decisions.

Please directly contact econtact@cnchemicals.com to specify your Market Research Requirement